Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NGENIC.ST Stock Summary
Top 10 Correlated ETFs
NGENIC.ST
In the News
NGENIC.ST Financial details
Company Rating
Sell
Market Cap
49.94M
Income
-20.1M
Revenue
69.84M
Book val./share
2.64
Cash/share
0.12
Dividend
-
Dividend %
-
Employees
64
Optionable
No
Shortable
Yes
Earnings
30 Nov 2023
P/E
-3.47
Forward P/E
-
PEG
1.53
P/S
1.56
P/B
3.62
P/C
74.17
P/FCF
-3.2
Quick Ratio
0.19
Current Ratio
0.93
Debt / Equity
0.5
LT Debt / Equity
0.5
-
-
EPS (TTM)
-2.94
EPS next Y
-
EPS next Q
-
EPS this Y
-22.63%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
4.06%
Revenue last 5Y
41.74%
Revenue Q/Q
17.68%
EPS Q/Q
27.69%
-
-
-
-
SMA20
-24.6%
SMA50
-43.58%
SMA100
-35.87%
Inst Own
-
Inst Trans
-
ROA
-30%
ROE
-79%
ROC
-0.52%
Gross Margin
69%
Oper. Margin
-44%
Profit Margin
-45%
Payout
-
Shs Outstand
6.84M
Shs Float
5.05M
-
-
-
-
Target Price
-
52W Range
6.68-23.0
52W High
-61.3%
52W Low
+48.33%
RSI
51.6
Rel Volume
2.68
Avg Volume
4.49K
Volume
12.02K
Perf Week
15.89%
Perf Month
-6.32%
Perf Quarter
-33.33%
Perf Half Y
-43.49%
-
-
-
-
Beta
0.253
-
-
Volatility
0.72%, 1.12%
Prev Close
27.51%
Price
8.9
Change
73.83%
NGENIC.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.62 | 2.64 | 4.04 | 3.87 | 10.21 | |
Net income per share | -2.41 | -2.69 | -4.23 | -3.8 | -2.94 | |
Operating cash flow per share | -0.03 | -1.67 | -3.54 | -0.99 | -2.02 | |
Free cash flow per share | -0.98 | -2.67 | -4.85 | -2.5 | -3.77 | |
Cash per share | 0.53 | 1.38 | 2.57 | 1.58 | 0.12 | |
Book value per share | 0.5 | 1.14 | 8.14 | 5.65 | 2.64 | |
Tangible book value per share | -2.17 | -1.61 | -0.72 | -0.78 | 2.64 | |
Share holders equity per share | 0.5 | 1.14 | 8.14 | 5.65 | 2.64 | |
Interest debt per share | 1.32 | 1.61 | 3.77 | 1.21 | 1.49 | |
Market cap | 158.78M | 158.78M | 121.34M | 197.63M | 79.35M | |
Enterprise value | 162.14M | 159.08M | 135.35M | 194.45M | 87.58M | |
P/E ratio | -14.18 | -12.69 | -6.15 | -7.61 | -3.95 | |
Price to sales ratio | 13.01 | 12.92 | 6.44 | 7.47 | 1.14 | |
POCF ratio | -1.35K | -20.49 | -7.35 | -29.27 | -5.74 | |
PFCF ratio | -34.76 | -12.77 | -5.36 | -11.58 | -3.08 | |
P/B Ratio | 68.14 | 29.93 | 3.2 | 5.12 | 4.4 | |
PTB ratio | 68.14 | 29.93 | 3.2 | 5.12 | 4.4 | |
EV to sales | 13.28 | 12.94 | 7.18 | 7.35 | 1.25 | |
Enterprise value over EBITDA | -23.08 | -21.56 | -10.61 | -10.91 | -7.53 | |
EV to operating cash flow | -1.37K | -20.53 | -8.2 | -28.79 | -6.34 | |
EV to free cash flow | -35.49 | -12.8 | -5.98 | -11.39 | -3.4 | |
Earnings yield | -0.07 | -0.08 | -0.16 | -0.13 | -0.25 | |
Free cash flow yield | -0.03 | -0.08 | -0.19 | -0.09 | -0.32 | |
Debt to equity | 2.5 | 1.27 | 0.45 | 0.2 | 0.5 | |
Debt to assets | 0.27 | 0.27 | 0.26 | 0.1 | 0.12 | |
Net debt to EBITDA | -0.48 | -0.04 | -1.1 | 0.18 | -0.71 | |
Current ratio | 0.59 | 0.77 | 1.81 | 0.91 | 0.59 | |
Interest coverage | -35.35 | -14.82 | -31.3 | -38.87 | -19.39 | |
Income quality | 0.01 | 0.62 | 0.84 | 0.26 | 0.69 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.5 | 0.46 | 0.46 | 0 | 0 | |
Research and developement to revenue | 0.3 | 0.35 | 0.24 | 0.19 | 0 | |
Intangibles to total assets | 0.58 | 0.52 | 0.64 | 0.58 | 0 | |
Capex to operating cash flow | 37.7 | 0.6 | 0.37 | 1.53 | 0.86 | |
Capex to revenue | -0.36 | -0.38 | -0.33 | -0.39 | -0.17 | |
Capex to depreciation | -1.15 | -49.39 | -3.35 | -3.73 | -1.16 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.21 | 8.31 | 27.83 | 21.97 | 13.2 | |
ROIC | -1.33 | -0.98 | -0.35 | -0.55 | -0.8 | |
Return on tangible assets | -1.27 | -1.05 | -0.85 | -0.81 | -0.26 | |
Graham Net | -2.65 | -2.07 | -1.56 | -2.06 | -5.99 | |
Working capital | -5.9M | -3.63M | 10.17M | -3M | -20.64M | |
Tangible asset value | -10.08M | -7.48M | -3.34M | -5.34M | 18.03M | |
Net current asset value | -10.23M | -7.6M | -3.69M | -7.85M | -30.15M | |
Invested capital | 2.5 | 1.27 | 0.45 | 0.2 | 0.5 | |
Average receivables | 0 | 3.34M | 5.01M | 9.89M | 14.56M | |
Average payables | 0 | 786.18K | 1.83M | 4.64M | 3.18M | |
Average inventory | 0 | 2.46M | 3.1M | 4.87M | 8.93M | |
Days sales outstanding | 117.06 | 82.13 | 140.38 | 172.92 | 86.67 | |
Days payables outstanding | -187.43 | -109.69 | 4.09K | 1.51K | 0 | |
Days of inventory on hand | -510.53 | -394.2 | 4.95K | 1.47K | 46.4 | |
Receivables turnover | 3.12 | 4.44 | 2.6 | 2.11 | 4.21 | |
Payables turnover | -1.95 | -3.33 | 0.09 | 0.24 | 0 | |
Inventory turnover | -0.71 | -0.93 | 0.07 | 0.25 | 7.87 | |
ROE | -4.81 | -2.36 | -0.52 | -0.67 | -1.11 | |
Capex per share | -0.96 | -1.01 | -1.31 | -1.51 | -1.75 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.24 | 2.06 | 1.92 | 2.86 | 3.37 | |
Net income per share | -1.55 | -0.46 | -1 | -0.65 | -0.83 | |
Operating cash flow per share | -0.7 | -1.2 | -1.34 | 1.05 | -0.52 | |
Free cash flow per share | -1.06 | -1.72 | -1.79 | 0.61 | -0.87 | |
Cash per share | 1.61 | 0.19 | 0.51 | 0.97 | 0.12 | |
Book value per share | 5.75 | 5.1 | 4.15 | 3.48 | 2.64 | |
Tangible book value per share | -0.79 | -1.54 | -2.71 | 3.48 | 2.64 | |
Share holders equity per share | 5.75 | 5.1 | 4.15 | 3.48 | 2.64 | |
Interest debt per share | 1.15 | 1.05 | 3.32 | 3.31 | 1.37 | |
Market cap | 194.18M | 115.6M | 129.97M | 105.69M | 79.35M | |
Enterprise value | 191M | 121.37M | 148.91M | 121.34M | 87.58M | |
P/E ratio | -4.66 | -9.25 | -4.74 | -5.97 | -3.48 | |
Price to sales ratio | 23.36 | 8.21 | 9.88 | 5.4 | 3.45 | |
POCF ratio | -41.32 | -14.07 | -14.17 | 14.76 | -22.12 | |
PFCF ratio | -27.29 | -9.85 | -10.6 | 25.29 | -13.38 | |
P/B Ratio | 5.03 | 3.31 | 4.58 | 4.43 | 4.4 | |
PTB ratio | 5.03 | 3.31 | 4.58 | 4.43 | 4.4 | |
EV to sales | 22.98 | 8.62 | 11.32 | 6.2 | 3.8 | |
Enterprise value over EBITDA | -25.43 | -172.4 | -36.07 | -91.1 | -31.45 | |
EV to operating cash flow | -40.64 | -14.77 | -16.23 | 16.94 | -24.42 | |
EV to free cash flow | -26.84 | -10.34 | -12.14 | 29.04 | -14.77 | |
Earnings yield | -0.05 | -0.03 | -0.05 | -0.04 | -0.07 | |
Free cash flow yield | -0.04 | -0.1 | -0.09 | 0.04 | -0.07 | |
Debt to equity | 0.2 | 0.2 | 0.79 | 0.94 | 0.5 | |
Debt to assets | 0.1 | 0.1 | 0.31 | 0.27 | 0.12 | |
Net debt to EBITDA | 0.42 | -8.19 | -4.59 | -11.75 | -2.96 | |
Current ratio | 0.91 | 0.79 | 1.09 | 0.93 | 0.59 | |
Interest coverage | -138.2 | -20.53 | -21.63 | -11.8 | -16.78 | |
Income quality | 0.44 | 2.6 | 1.33 | -1.6 | 0.63 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0.59 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.58 | 0.67 | 0.64 | 0.57 | 0 | |
Capex to operating cash flow | 0.51 | 0.43 | 0.34 | -0.42 | 0.65 | |
Capex to revenue | -0.29 | -0.25 | -0.23 | -0.15 | -0.1 | |
Capex to depreciation | -0.81 | -1.52 | -1.26 | -1.07 | -0.87 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 14.16 | 7.24 | 9.67 | 7.12 | 7.03 | |
ROIC | -0.22 | -0.07 | -0.13 | -0.09 | -0.2 | |
Return on tangible assets | -0.32 | -0.14 | -0.26 | -0.13 | -0.07 | |
Graham Net | -2.1 | -3.37 | -4.42 | -5.3 | -5.99 | |
Working capital | -3M | -5.42M | 1.86M | -2.29M | -20.64M | |
Tangible asset value | -5.34M | -10.57M | -18.54M | -22.59M | 18.03M | |
Net current asset value | -7.85M | -13.09M | -21.15M | -25.1M | -30.15M | |
Invested capital | 0.2 | 0.2 | 0.79 | 0.94 | 0.5 | |
Average receivables | 9.75M | 9.63M | 8.15M | 11.55M | 15.05M | |
Average payables | 3.18M | 3.18M | 0 | 0 | 0 | |
Average inventory | 4.97M | 7.13M | 8.03M | 8.56M | 10.39M | |
Days sales outstanding | 135.77 | 43.02 | 65.51 | 62.19 | 64.81 | |
Days payables outstanding | 266.56 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 259.86 | 257.48 | 202.01 | 95.07 | 36.8 | |
Receivables turnover | 0.66 | 2.09 | 1.37 | 1.45 | 1.39 | |
Payables turnover | 0.34 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0.35 | 0.35 | 0.45 | 0.95 | 2.45 | |
ROE | -0.27 | -0.09 | -0.24 | -0.19 | -0.32 | |
Capex per share | -0.36 | -0.52 | -0.45 | -0.44 | -0.34 |
NGENIC.ST Frequently Asked Questions
What is Ngenic AB (publ) stock symbol ?
Ngenic AB (publ) is a SE stock and trading under the symbol NGENIC.ST
What is Ngenic AB (publ) stock quote today ?
Ngenic AB (publ) stock price is $8.9 today.
Is Ngenic AB (publ) stock public?
Yes, Ngenic AB (publ) is a publicly traded company.